Calcium
Compiled from published pharmacological and botanical literature. Not independently verified by Herbuno. Spotted an error or have a correction? Flag it below →
| Compound Class | Essential macromineral (divalent cation, Ca2+); most abundant mineral in the human body |
| Botanical Source | Wrightia tinctoria — Indrajao / Sweet Indrajao; calcium native to the plant matrix |
| Standardisation | 12% elemental calcium by ICP-MS or flame AAS |
| Comparator Forms | Calcium carbonate, citrate, phosphate, lactate, gluconate; coral and algal calcium |
| Solubility / Format | Fine powder; matrix-bound calcium; suited to tablets, capsules and powder blends |
| Regulatory Note | Established NRV and authorised EU health claims; claims attach to elemental calcium content |
| Buy from Herbuno | Wrightia tinctoria 12% |
| Origin | Processed / Sourced from India |
| MOQ | R&D 100 g / 250 g (subject to stock) · Pilot batch 1–5 kg · Bulk 10 kg, 25 kg and above |
| Lead Time | Dispatch within 72 hrs from stock · fresh-batch production (typically 50 kg+): 10 working days |
| Documentation | CoA & MSDS standard with every lot; phytosanitary on request |
Name origin: Calcium takes its name from the Latin calx, lime — the burnt limestone that has been a building material since antiquity. Humphry Davy isolated the metal in 1808 by electrolysis of lime, the same year he isolated magnesium. The nutritional understanding developed much later, though the practice of consuming calcareous materials for bone complaints considerably predates the chemistry.
Traditional use: Wrightia tinctoria occupies a genuine place in Indian ethnomedicine, principally in dermatology — leaf and bark preparations appear in Ayurvedic and Siddha practice for psoriasis and other skin conditions, and the plant is also a traditional indigo dye source, which is where the species epithet tinctoria comes from. Its use as a calcium-bearing biomass is a modern analytical application, not a traditional one, and the two should not be run together on a label.
Research trajectory: Calcium research followed a confident trajectory through the twentieth century — establish the bone reservoir, define requirements, supplement to prevent osteoporotic fracture. The past fifteen years have complicated that story considerably. Large trials and meta-analyses have failed to show the fracture benefit the model predicted, and attention has shifted toward whether the timing of intake across the lifespan matters more than total supplemental dose in later life.
Commercial source: Supplemental calcium is dominated by calcium carbonate, cheap and high in elemental content at around 40%, followed by citrate at roughly 21%. Mineral-derived alternatives such as coral and algal calcium occupy a natural-source niche. Plant-matrix calcium is a distinct and much smaller category, and given the inclusion arithmetic set out below it is a positioning ingredient rather than a dose-delivery ingredient.
Evidence for Calcium Applications
Calcium's structural role is not in question: roughly 99% of body calcium resides in bone and teeth as hydroxyapatite, and the remainder is tightly regulated for neuromuscular signalling, coagulation and intracellular messaging. Because serum calcium is defended homeostatically at the expense of the skeleton, blood calcium is useless as a status marker — a point that matters when evaluating any claim about calcium status. Claim strength: High.
Where the evidence has moved against the conventional commercial narrative is on supplementation outcomes in older adults, and a supplier should represent that accurately. A systematic review and meta-analysis of 33 randomised clinical trials including 51,145 community-dwelling participants examined whether calcium, vitamin D, or the combination was associated with lower fracture incidence. [Zhao 2017] The finding was not the one the supplement category is built on, and it is consistent across several independent analyses. Claim strength: High.
The mechanistic reason is instructive. A meta-regression of 15 randomised placebo-controlled trials with 47,365 participants, most drawn from the Women's Health Initiative, examined whether changes in bone mineral density predicted fracture reduction. Larger increases in lumbar spine BMD were not associated with greater fracture risk reduction, though a statistically significant relationship was found for hip BMD; the authors concluded there was no evidence of a relationship between BMD changes and fracture risk reduction, and suggested any benefit may operate through a mechanism independent of bone density. [Rabenda 2011] Improving a surrogate marker is not the same as improving the outcome. Claim strength: High.
What this means commercially is that calcium should be positioned as an essential nutrient supporting normal bone maintenance — which is both true and claimable — rather than as a fracture-prevention intervention in older adults, which the trial evidence does not support. Evidence is more encouraging for calcium intake during the bone-accrual years before peak bone mass, where improving attained BMD is the plausible mechanism. That is a different product and a different audience. Claim strength: Moderate.
For a plant-matrix calcium specifically, no head-to-head human absorption study compares a Wrightia tinctoria concentrate against carbonate or citrate, and we will not imply otherwise. Two general absorption principles do apply and are worth designing around: calcium absorption is dose-limited, with fractional absorption falling as a single dose rises above roughly 500 mg elemental, so divided dosing outperforms a single large dose; and carbonate requires gastric acid for dissolution while citrate does not, which is why citrate is preferred for older adults and those on acid-suppressing medication. Claim strength: Moderate.
Sourcing botanical calcium: A 12% elemental calcium concentrate from Wrightia tinctoria is available from Herbuno, assayed by ICP-MS, with CoA and MSDS on every lot. View Calcium 12% →
Dosage & Formulator Specification
Production route. Plant biomass is processed and concentrated to a 12% elemental calcium specification. At 12% this material is considerably richer than the single-digit botanical minerals in this range, but it remains far below calcium carbonate at roughly 40%. Delivering 200 mg of elemental calcium requires approximately 1.67 g of this material against 500 mg of carbonate — so a full NRV of calcium from this ingredient alone is not achievable in a conventional tablet or capsule, and product design should proceed from that fact rather than discover it later.
Analytical standardisation. Elemental calcium is determined by ICP-MS or flame AAS after acid digestion, with ICP-MS preferred where the same digest screens heavy metals. Lead is the parameter warranting particular attention for any calcium material, as calcium sources have historically been a route of lead exposure, and it should carry an explicit limit rather than sitting inside a general heavy metals statement. State the assay method on the purchase specification alongside the percentage.
Regulatory and handling context. Calcium has an established Nutrient Reference Value in the EU and authorised health claims covering maintenance of normal bones and teeth, normal blood clotting, normal muscle function, normal neurotransmission and normal energy-yielding metabolism. Claims attach to elemental calcium content and are source-indifferent. Tolerable upper intake levels apply to total calcium from all sources; excessive intake is associated with hypercalcaemia, kidney stone risk in susceptible individuals, and impaired absorption of iron and zinc through competition, which is a real formulation consideration in multi-minerals. Store cool and dry.
Formulation behaviour. The inclusion arithmetic governs everything. Realistic applications are powder blends, functional foods and bone-support formulas where this material contributes part of the calcium alongside a conventional salt, or where clean-label positioning rather than dose is the objective. Do not co-formulate at high calcium inclusion with iron or zinc without considering absorption competition — separating them across a dosing schedule is the usual solution. Calcium salts are also poor tabletting materials at high inclusion, and a plant-matrix material behaves differently again, so compression trials should be run early rather than assumed from a carbonate formulation.
Frequently Asked Questions — Calcium
The trial evidence in community-dwelling older adults does not support that claim, and we would rather state it plainly than sell past it. A meta-analysis of 33 randomised trials including 51,145 participants examined calcium, vitamin D and the combination against fracture incidence and did not find the benefit the category is built on. A separate meta-regression of 15 trials found no evidence of a relationship between bone mineral density changes and fracture risk reduction. Calcium remains an essential nutrient for normal bone maintenance; that is the defensible position.
Not from this ingredient alone in a conventional dose form. At 12% elemental calcium, delivering 200 mg requires about 1.67 grams of material, against 500 mg of calcium carbonate. Realistic applications are powder blends, functional foods, or formulas where this material provides part of the calcium alongside a conventional salt while carrying the clean-label position.
No head-to-head human absorption study compares this material against carbonate or citrate, so we cannot claim an advantage. Two general principles apply to any calcium source: absorption is dose-limited, with fractional absorption falling above roughly 500 mg elemental in a single dose, so divided dosing is better; and carbonate needs gastric acid to dissolve while citrate does not, which matters for older adults and anyone on acid-suppressing medication.
Lead, specifically and explicitly. Calcium sources have historically been a route of lead exposure, so we recommend an explicit lead limit on the specification rather than relying on a general heavy metals statement. Beyond that, confirm the assay method for elemental calcium, since a percentage without a stated method is not a specification.
Yes. Calcium competes with iron and zinc for absorption, so high calcium inclusion alongside those minerals in a single dose form reduces the delivered benefit of all three. The usual solution is separating them across a dosing schedule rather than reformulating. Also note that calcium salts are difficult tabletting materials at high inclusion and a plant-matrix material behaves differently again, so run compression trials early.
Every lot ships with a Certificate of Analysis and MSDS as standard, with phytosanitary certification on request. R&D quantities are available at 100 g and 250 g subject to stock, pilot batches at 1–5 kg, and bulk at 10 kg, 25 kg and above. Stock orders dispatch within 72 hours; fresh-batch production, typically 50 kg and above, runs to about 10 working days. Material is processed and sourced in India.
Related compounds: Magnesium · Vitamin D3 · Vitamin K2-MK7
Claim strength scale: High — consistent human data or established biochemistry. Moderate — supportive human data with limitations. Emerging — mechanistic or preliminary evidence only.